These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer. Lu YJ; Liu RY; Hu K; Wang Y Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300 [TBL] [Abstract][Full Text] [Related]
23. MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis. Yang W; Bai J; Liu D; Wang S; Zhao N; Che R; Zhang H Gene; 2018 Mar; 647():13-20. PubMed ID: 29309884 [TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression. Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417 [TBL] [Abstract][Full Text] [Related]
25. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1. Zheng J; Xu T; Chen F; Zhang Y Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control. Tanigawa K; Misono S; Mizuno K; Asai S; Suetsugu T; Uchida A; Kawano M; Inoue H; Seki N Mol Oncol; 2023 Feb; 17(2):328-343. PubMed ID: 36345848 [TBL] [Abstract][Full Text] [Related]
27. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer. Wang K; Chen M; Wu W World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412 [TBL] [Abstract][Full Text] [Related]
28. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer. Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708 [TBL] [Abstract][Full Text] [Related]
29. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Xiao P; Liu WL Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792 [TBL] [Abstract][Full Text] [Related]
30. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles. Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219 [TBL] [Abstract][Full Text] [Related]
31. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2. Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794 [TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p. Lu Q; Shan S; Li Y; Zhu D; Jin W; Ren T FASEB J; 2018 Jul; 32(7):3957-3967. PubMed ID: 29466052 [TBL] [Abstract][Full Text] [Related]
33. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR. Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946 [TBL] [Abstract][Full Text] [Related]
34. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer. Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168 [TBL] [Abstract][Full Text] [Related]
35. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation. Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218 [TBL] [Abstract][Full Text] [Related]
36. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451 [TBL] [Abstract][Full Text] [Related]
37. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951 [TBL] [Abstract][Full Text] [Related]
39. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma. Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582 [TBL] [Abstract][Full Text] [Related]
40. Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma. Mataki H; Seki N; Chiyomaru T; Enokida H; Goto Y; Kumamoto T; Machida K; Mizuno K; Nakagawa M; Inoue H Int J Oncol; 2015 Mar; 46(3):1039-50. PubMed ID: 25522678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]